SM30 30mg*10vials

Semaglutide SM30 30mg*10vials

Semaglutide is a GLP-1 receptor agonist peptide that mimics the body's natural incretin hormone, representing a high-concentration metabolic research compound.

The 30mg single-vial specification delivers a substantial active ingredient load per vial. This formulation is designed for ultra-long-term large animal studies, high-dose efficacy validation experiments, and large-scale multi-group parallel research projects. The high concentration per vial minimizes the number of vials required for extended experimental timelines, effectively reducing data variability and operational errors from repeated dilution and solution preparation.

Through GLP-1 receptor activation, this compound supports advanced research into insulin secretion regulation, glycemic control pathways, appetite-related signaling, and metabolic homeostasis. It serves as a foundational research tool for investigating gut hormone effects on systemic metabolism and long-term body weight regulation.

This product is supplied as sterile lyophilized powder in glass vials, formulated for reconstitution with bacteriostatic water. Each batch undergoes comprehensive purity testing, with a full certificate of analysis provided.

10 vials per pack, designed for large-scale preclinical research and extended laboratory projects.